Design of potent inhibitors of human beta-secretase. Part 1.
Freskos, J.N., Fobian, Y.M., Benson, T.E., Bienkowski, M.J., Brown, D.L., Emmons, T.L., Heintz, R., Laborde, A., McDonald, J.J., Mischke, B.V., Molyneaux, J.M., Moon, J.B., Mullins, P.B., Bryan Prince, D., Paddock, D.J., Tomasselli, A.G., Winterrowd, G.(2007) Bioorg Med Chem Lett 17: 73-77
- PubMed: 17046251 
- DOI: https://doi.org/10.1016/j.bmcl.2006.09.092
- Primary Citation of Related Structures:  
2HIZ - PubMed Abstract: 
We describe a novel series of potent inhibitors of human beta-secretase. These compounds possess the hydroxyethyl amine transition state isostere. A 2.5A crystal structure of inhibitor 32 bound to BACE is provided.
Organizational Affiliation: 
Pfizer Inc., 700N. Chesterfield Pkwy., St. Louis, MO 63198, USA. john.n.freskos@pfizer.com